Jiao Jia
Biographic Data
| ID | 7384228 |
|---|---|
| NAME | Jiao Jia |
| GIVEN NAMES | Jiao |
| FAMILY NAME | Jia |
| SIGNATURE | JIA J |
| AFFILIATIONS | Shanxi Academy of Medical Sciences |
| ORCID | 0000-0003-0965-5217 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies
This study identified the metabolic biomarkers for different clinical phases of bipolar disorder (BD) through metabolomics. BD patients were divided into three groups: patients with BD and depressive episodes (BE, n = 59), patients with BD and mania/hypomania episodes (BH, n = 16), patients with BD and mixed episodes (BM, n = 10), and healthy controls (HC, n = 10). Serum from participants was collected for metabolomic sequencing, biomarkers from …
Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
Glycerolipid metabolism is significantly involved in BD and MDD. Pyruvate metabolism is significantly involved in MDD. Pyruvate, choline, and acetate may be potential biomarkers for MDD to distinguish from BD, and pantothenic acid may be a potential biomarker for BD to distinguish from MDD
Pre- and Post-treatment Levels of Plasma Metabolites in Patients With Bipolar Depression
Background: Bipolar disorder (BD) is a serious mental disease with complex clinical manifestations and high recurrence rate. The purpose of this study was to detect metabolites related to the diagnosis and efficacy evaluation of bipolar depression in plasma samples by metabolomics. Methods: Thirty-one bipolar depression patients were recruited and completed 8 weeks medication and a matched group of 47 healthy controls (HCs) was recruited. Nuclear…
No prominent works on this page.
Pre- and Post-treatment Levels of Plasma Metabolites in Patients With Bipolar Depression
Background: Bipolar disorder (BD) is a serious mental disease with complex clinical manifestations and high recurrence rate. The purpose of this study was to detect metabolites related to the diagnosis and efficacy evaluation of bipolar depression in plasma samples by metabolomics. Methods: Thirty-one bipolar depression patients were recruited and completed 8 weeks medication and a matched group of 47 healthy controls (HCs) was recruited. Nuclear…
Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis
Glycerolipid metabolism is significantly involved in BD and MDD. Pyruvate metabolism is significantly involved in MDD. Pyruvate, choline, and acetate may be potential biomarkers for MDD to distinguish from BD, and pantothenic acid may be a potential biomarker for BD to distinguish from MDD
Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies
This study identified the metabolic biomarkers for different clinical phases of bipolar disorder (BD) through metabolomics. BD patients were divided into three groups: patients with BD and depressive episodes (BE, n = 59), patients with BD and mania/hypomania episodes (BH, n = 16), patients with BD and mixed episodes (BM, n = 10), and healthy controls (HC, n = 10). Serum from participants was collected for metabolomic sequencing, biomarkers from …
Bipolar disorder (3 works) · Bipolar Disorder and Treatment (3 works) · Medicine (3 works) · Tryptophan and brain disorders (3 works) · Bioinformatics (2 works) · Biology (2 works) · Internal Medicine (2 works) · Lithium (medication (2 works) · Metabolomics (2 works) · Psychiatry (2 works)